Discovery of Selective Cannabinoid CB 2 Receptor Agonists by High-Throughput Screening.

Autor: Ogawa LM; 1 Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, CT, USA., Burford NT; 2 Bristol-Myers Squibb, Research and Development, Wallingford, CT, USA., Liao YH; 3 Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA., Scott CE; 3 Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA., Hine AM; 3 Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA., Dowling C; 2 Bristol-Myers Squibb, Research and Development, Wallingford, CT, USA., Chin J; 2 Bristol-Myers Squibb, Research and Development, Wallingford, CT, USA., Power M; 2 Bristol-Myers Squibb, Research and Development, Wallingford, CT, USA., Hunnicutt EJ Jr; 2 Bristol-Myers Squibb, Research and Development, Wallingford, CT, USA., Emerick VL; 2 Bristol-Myers Squibb, Research and Development, Wallingford, CT, USA., Banks M; 2 Bristol-Myers Squibb, Research and Development, Wallingford, CT, USA., Zhang L; 2 Bristol-Myers Squibb, Research and Development, Wallingford, CT, USA., Gerritz SW; 2 Bristol-Myers Squibb, Research and Development, Wallingford, CT, USA., Alt A; 2 Bristol-Myers Squibb, Research and Development, Wallingford, CT, USA., Kendall DA; 3 Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA.

Publikováno v: SLAS discovery : advancing life sciences R & D [SLAS Discov] 2018 Apr; Vol. 23 (4), pp. 375-383. Date of Electronic Publication: 2017 Dec 19.

A new glibenclamide-insensitive neuroselective hyperpolarizing agent.

Autor: Hunnicutt EJ Jr; Miles Institute for Dementia Research, West Haven, CT 06516., Davis JN, Chisholm JC

Publikováno v: European journal of pharmacology [Eur J Pharmacol] 1994 Aug 11; Vol. 261 (1-2), pp. R1-3.